Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Jun;41(6):1253-61.
doi: 10.1017/S0033291710001765. Epub 2010 Sep 22.

Mechanisms of functional improvement in a 2-year trial of cognitive enhancement therapy for early schizophrenia

Affiliations
Randomized Controlled Trial

Mechanisms of functional improvement in a 2-year trial of cognitive enhancement therapy for early schizophrenia

S M Eack et al. Psychol Med. 2011 Jun.

Abstract

Background: Cognitive rehabilitation has emerged as an effective treatment for addressing cognitive impairments and functional disability in schizophrenia; however, the degree to which changes in various social and non-social cognitive processes translate into improved functioning during treatment remains unclear. This research sought to identify the neurocognitive and social-cognitive mechanisms of functional improvement during a 2-year trial of cognitive enhancement therapy (CET) for early-course schizophrenia.

Method: Patients in the early course of schizophrenia were randomly assigned to CET (n=31) or an enriched supportive therapy control (n=27) and treated for up to 2 years. A comprehensive neurocognitive assessment battery and the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT) were completed annually, along with measures of functioning. Mediator analyses using mixed-effects growth models were conducted to examine the effects of neurocognitive and social-cognitive improvement on functional change.

Results: Improvements over 2 years in neurocognition and the emotion management branch of the MSCEIT were found to be significantly related to improved functional outcome in early-course schizophrenia patients. Neurocognitive improvement, primarily in executive functioning, and social-cognitive change in emotion management also mediated the robust effects of CET on functioning.

Conclusions: Improvements in neurocognition and social cognition that result from cognitive rehabilitation are both significant mediators of functional improvement in early-course schizophrenia. Cognitive rehabilitation programs for schizophrenia may need to target deficits in both social and non-social cognition to achieve an optimal functional response.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interest

The authors report no competing financial or other conflicts of interest with this research.

Figures

Figure 1
Figure 1
Neurocognitive and Social-Cognitive Mediators of the Effects of Cognitive Enhancement Therapy on Functional Outcome in Early Course Schizophrenia (N = 58). Note. Regression weights on the left and right of the slash (/) represent direct and indirect effects, respectively. *p < .05, **p < .01

References

    1. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology. 1986;51(6):1173–1182. - PubMed
    1. Braw Y, Bloch Y, Mendelovich S, Ratzoni G, Gal G, Harari H, Tripto A, Levkovitz Y. Cognition in young schizophrenia outpatients: comparison of first-episode with multiepisode patients. Schizophrenia Bulletin. 2008;34(3):544–554. - PMC - PubMed
    1. Brekke JS, Hoe M, Green MF. Neurocognitive change, functional change and service intensity during community-based psychosocial rehabilitation for schizophrenia. Psychological Medicine (in press) - PubMed
    1. Brekke JS, Hoe M, Long J, Green MF. How Neurocognition and Social Cognition Influence Functional Change During Community-Based Psychosocial Rehabilitation for Individuals with Schizophrenia. Schizophrenia Bulletin. 2007;33(5):1247–1256. - PMC - PubMed
    1. Buchanan RW, Heinrichs DW. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Research. 1989;27(3):335–350. - PubMed

Publication types

MeSH terms